;

Synthetic Organic Chemistry

What is Synthetic Organic Chemistry?

 

Teva api process development and production capabilities in synthetic organic chemistry cover a broad range of synthetic products and state-of-the-art technologies. Our development expertise is backed by our comprehensive understanding of these processes and an unwavering commitment to R&D investment. As a result, we provide you with high-quality APIs, while meeting the most stringent industry standards.

 

Our capabilities in the field of synthetic organic chemistry include the majority of reaction types, among others: O-alkylation, N-alkylation, aliphatic and aromatic nucleophilic substitution, catalytic hydrogenation, catalytic reduction, biocatalysis, redox reactions, photochemical reactions, organometallic reactions, stereoselective reactions, multicomponent reactions, catalytic reactions.

Teva api's Synthetic Organic Chemistry process

 

Teva api provides a robust synthetic process from API conception all the way to commercial production. This process is specifically designed to be atom-efficient, safe and environmentally friendly without compromising product purity. The most rigid analytical and physical control methods are utilized to deliver desired polymorphs compatible with the stringent demands of regulatory bodies in target countries. And, our knowledgeable IP experts are available to answer questions and help you maintain your competitive edge in the marketplace.

Teva api operates five R&D centers worldwide. There, our top researchers with wide-ranging scientific expertise continually strive to bring new APis to the market and to improve our processes so you benefit from industry-leading learnings and materials. Scientists in several of Teva api’s large pilot plants – with capacities ranging from 200 ml to 480 l – are developing technologies to deliver and implement new processes that will enhance our production capabilities.

Teva api's products, which involve the use of synthetic organic chemistry expertise, are varied and include API products such as: VenetoclaxIxazomib CitrateBortezomib,Apixaban and more